26.07.2019 • News • Michael Quirmbach • Corden Pharma • People

Michael Quirmbach Appointed as CEO and President of CordenPharma

CordenPharma has appointed Michael Quirmbach as its new CEO and president....
CordenPharma has appointed Michael Quirmbach as its new CEO and president. Source: CordenPharma

CordenPharma has appointed Michael Quirmbach as its new CEO and president, effective Aug. 1, 2019. He is going to succeed Riku Rautsola who will transition to the role of a senior advisor to the executive leadership team.

Quirmbach joined CordenPharma in October 2014 as chief business officer and has been a member of the executive leadership team. Prior to joining CordenPharma, he held several management positions at Siegfried, Dr. Reddy’s and Solvias. Quirmbach holds a degree in chemistry and a PhD from the Max Planck Research Group at the Institute for Organic Catalysis Research in Rostock, Germany, as well as an MBA from La Salle University in Philadelphia, USA.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Top-Feature